The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models. (Q37287418)
Jump to navigation
Jump to search
scientific article published on 09 June 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models. |
scientific article published on 09 June 2009 |
Statements
The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models (English)
N Faur
L Araud
A Laroche-Clary
J Kanno
T Yamori
1 reference
1 reference
1 reference
1 reference
1 reference